Racial and ethnic differences in colon cancer surgery type performed and delayed treatment among people 45 years old and older in the USA between 2007 and 2017: Mediating effect on survival

IF 2.3 4区 医学 Q3 ONCOLOGY
Pierre Fwelo , Oladipo Afolayan , Kenechukwu O.S. Nwosu , Akpevwe A. Ojaruega , Onyekachi Ahaiwe , Olajumoke A. Olateju , Ogochukwu Juliet Ezeigwe , Toluwani E. Adekunle , Ayrton Bangolo
{"title":"Racial and ethnic differences in colon cancer surgery type performed and delayed treatment among people 45 years old and older in the USA between 2007 and 2017: Mediating effect on survival","authors":"Pierre Fwelo ,&nbsp;Oladipo Afolayan ,&nbsp;Kenechukwu O.S. Nwosu ,&nbsp;Akpevwe A. Ojaruega ,&nbsp;Onyekachi Ahaiwe ,&nbsp;Olajumoke A. Olateju ,&nbsp;Ogochukwu Juliet Ezeigwe ,&nbsp;Toluwani E. Adekunle ,&nbsp;Ayrton Bangolo","doi":"10.1016/j.suronc.2023.101983","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>This study examined the associations of socioeconomic status (SES), race/ethnicity, surgery type, and treatment delays with mortality among colon cancer patients. In addition, the study also quantifies the extent to which clinical and SES factors’ variations explain the racial/ethnic differences in overall survival.</p></div><div><h3>Patients and methods</h3><p>We studied 111,789 adult patients ≥45 years old who were diagnosed with colon cancer between 2010 and 2017, identified from the Surveillance, Epidemiology, and End Results (SEER) database. We performed logistic regression models to examine the association of SES and race/ethnicity with surgery type and first course of treatment delays. We also performed mediation analysis to quantify the extent to which treatment, sociodemographic and clinicopathologic factors mediated racial/ethnic differences in survival.</p></div><div><h3>Results</h3><p>Non-Hispanic (NH) Blacks [adjusted Odds Ratio (aOR) = 1.19, 95% CI:1.13–1.25] were significantly more likely to undergo subtotal colectomy and to experience treatment delays [aOR = 1.39, 95% CI: 1.31–1.48] compared to NH Whites. Hispanics [aOR = 1.59, 95% CI: 1.49–1.69] were more likely to experience treatment delays than NH Whites. Delayed first course of treatment explained 23.56% and 56.73% of the lower survival among NH Blacks and Hispanics, respectively, compared to their NH White counterparts.</p></div><div><h3>Conclusions</h3><p>Race/ethnicity is significantly associated with the surgery type performed and the first course of treatment delays. Variations in treatment, SES, and clinicopathological factors significantly explained racial disparities in overall mortality. These disparities highlight the need for multidisciplinary interventions to address the treatment and social factors perpetuating racial disparities in colon cancer mortality.</p></div>","PeriodicalId":51185,"journal":{"name":"Surgical Oncology-Oxford","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical Oncology-Oxford","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S096074042300083X","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

This study examined the associations of socioeconomic status (SES), race/ethnicity, surgery type, and treatment delays with mortality among colon cancer patients. In addition, the study also quantifies the extent to which clinical and SES factors’ variations explain the racial/ethnic differences in overall survival.

Patients and methods

We studied 111,789 adult patients ≥45 years old who were diagnosed with colon cancer between 2010 and 2017, identified from the Surveillance, Epidemiology, and End Results (SEER) database. We performed logistic regression models to examine the association of SES and race/ethnicity with surgery type and first course of treatment delays. We also performed mediation analysis to quantify the extent to which treatment, sociodemographic and clinicopathologic factors mediated racial/ethnic differences in survival.

Results

Non-Hispanic (NH) Blacks [adjusted Odds Ratio (aOR) = 1.19, 95% CI:1.13–1.25] were significantly more likely to undergo subtotal colectomy and to experience treatment delays [aOR = 1.39, 95% CI: 1.31–1.48] compared to NH Whites. Hispanics [aOR = 1.59, 95% CI: 1.49–1.69] were more likely to experience treatment delays than NH Whites. Delayed first course of treatment explained 23.56% and 56.73% of the lower survival among NH Blacks and Hispanics, respectively, compared to their NH White counterparts.

Conclusions

Race/ethnicity is significantly associated with the surgery type performed and the first course of treatment delays. Variations in treatment, SES, and clinicopathological factors significantly explained racial disparities in overall mortality. These disparities highlight the need for multidisciplinary interventions to address the treatment and social factors perpetuating racial disparities in colon cancer mortality.

2007年至2017年间,美国45岁及以上人群结肠癌癌症手术类型和延迟治疗的种族和民族差异:对生存的中介作用。
背景:本研究调查了社会经济地位(SES)、种族/民族、手术类型和治疗延误与癌症患者死亡率的关系。此外,该研究还量化了临床和SES因素的变化在多大程度上解释了总体生存率中的种族/民族差异。患者和方法:我们研究了111789名年龄≥45岁的成年患者,他们在2010年至2017年间被诊断为结肠癌癌症,这些患者来自监测、流行病学和最终结果(SEER)数据库。我们使用逻辑回归模型来检验SES和种族/民族与手术类型和第一个疗程延误的关系。我们还进行了中介分析,以量化治疗、社会人口统计学和临床病理因素在多大程度上介导了生存中的种族/民族差异。结果:非西班牙裔(NH)黑人[调整后的比值比(aOR)=1.19,95%CI:1.13-1.25]与NH白人相比,接受结肠次全切除术和治疗延迟的可能性明显更大[aOR=1.39,95%CI:1.31-1.48]。西班牙裔[aOR=1.59,95%CI:1.49-1.69]比NH白人更有可能经历治疗延误。延迟的第一个疗程解释了与NH白人相比,NH黑人和西班牙裔的生存率分别降低了23.56%和56.73%。结论:种族/民族与手术类型和第一个疗程的延误显著相关。治疗、SES和临床病理因素的差异显著解释了总体死亡率的种族差异。这些差异突出了多学科干预措施的必要性,以解决导致结肠癌癌症死亡率种族差异长期存在的治疗和社会因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Surgical Oncology-Oxford
Surgical Oncology-Oxford 医学-外科
CiteScore
4.50
自引率
0.00%
发文量
169
审稿时长
38 days
期刊介绍: Surgical Oncology is a peer reviewed journal publishing review articles that contribute to the advancement of knowledge in surgical oncology and related fields of interest. Articles represent a spectrum of current technology in oncology research as well as those concerning clinical trials, surgical technique, methods of investigation and patient evaluation. Surgical Oncology publishes comprehensive Reviews that examine individual topics in considerable detail, in addition to editorials and commentaries which focus on selected papers. The journal also publishes special issues which explore topics of interest to surgical oncologists in great detail - outlining recent advancements and providing readers with the most up to date information.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信